Delivery Order SPE2DB24D2205-SPE2DB25FDZTD
- Not listed
- This federal contract award is for the delivery of Atropine 1 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The $1,297.41 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024. The contract has an ultimate completion date of November 1, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Atropine 1 mg/ml vials to the Defense Logistics Agency (DLA). The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,729.88 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award is for the delivery of Atropine 1 mg/mL vials to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a $6,767.90 firm-fixed-price delivery order with an ultimate completion date of August 25, 2022. It is not associated with any set-aside designation....
- This federal contract award, valued at $1,236.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATROPINE 1 MG/10 ML SYRINGE 10ML, a critical medical commodity, with a performance period ending on June 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves...
- This federal contract award is for the delivery of Atropine 1 mg/ml vials to the Medical Supply Chain of the Defense Logistics Agency (DLA). The $1,098.24 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. This award is a child contract under a larger $999,999,999.00 indefinite delivery contract (IDC) that serves as the primary vehicle for Amerisourcebergen to provide...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order valued at $1,078.53 and is for the delivery of ATROPINE 8 MG/20 ML VIAL 20ML medical supplies. The contract has a firm fixed price pricing type and a final completion date of February 26, 2025. This contract award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major...
- This federal contract award is a delivery order valued at $2,241.04, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATROPINE 0.4 MG/ML VIAL, a medical product, with a period of performance running through July 11, 2025. The contract is designated as a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is for the supply of ATROPINE 8 MG/20 ML VIAL 20ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,097.59, is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
- This federal contract award, valued at $3,104.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564809701 - ATROPINE 1 MG/ML VIALML, a critical pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,194.31, is a Delivery Order for the supply of ATROPINE 1 MG/10ML 10S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FDZTDDelivery Order
This federal contract award is for the delivery of ATROPINE 1 MG/ML VIALML to the Defense Logistics Agency (DLA). The contract, valued at $1,886.51, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 19, 2025. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/18/25 |